LSBC, in partnership with Biotech Primer, is pleased to present BioBasics 201: Targeted Biologics for the Non-Scientist is an intensive, two-day course focused on vaccines, cell therapies, gene therapies, therapeutic antibodies, and RNA-based drugs. Biopharma’s inspiration for the development of targeted biologics is our own human immune system, so we begin with an in-depth explanation of immunology. The course then focuses on the science, challenges, and medical promise of next generation targeted biologics. BioBasics 201 is designed for the non-scientist who has taken BioBasics 101 or for those who understand the basics of DNA, RNA, proteins, and cell signaling. Taught by industry experts who explain how these complex drugs work in a simple, engaging manner.
Five Takeaways:
1. Understand the mechanisms used by the human body to protect itself against disease.
2. Fluency in vaccine platforms, how each protects against disease including Covid-19.
3. Rational of therapeutic antibody mechanisms of action, including monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, checkpoint inhibitors.
4. Compare and contrast types of DNA- and RNA-based therapies and how each cures disease.
5. Increased knowledge of cell therapies, including all variations of CAR-based therapies
Seating is limited, so register early to reserve your spot.
